Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 201530
Company: EXTROVIS
Company: EXTROVIS
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
METHOTREXATE SODIUM PRESERVATIVE FREE | METHOTREXATE SODIUM | EQ 1GM BASE/40ML (EQ 25MG BASE/ML) | INJECTABLE;INJECTION | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
03/29/2012 | ORIG-1 | Approval | Not Applicable |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
07/13/2021 | SUPPL-8 | Labeling-Package Insert |
Label is not available on this site. |
||
07/13/2021 | SUPPL-6 | Labeling-Package Insert |
Label is not available on this site. |
||
10/05/2015 | SUPPL-3 | Labeling-Container/Carton Labels |
Label is not available on this site. |